Experimental Hematology and Oncology

Biochemistry, Genetics and Molecular Biology · Medicine

Impact Factor
8.653
2022
H-Index
42.000
2023
SJR
2.384
2023

I. Journal Information

ISSN21623619
CountryUnited Kingdom
PublisherBioMed Central Ltd.
Subject AreasBiochemistry, Genetics and Molecular Biology · Medicine
Publication TypeJournals
Active Years2012-2021
WebsiteVisit journal
JIF 2022–20239.400

II. Scope & Description

Experimental HematologyOncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical basic patientoriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with negative results and basic science studies with provocative findings.Experimental HematologyOncology publishes original work hypothesis commentaries and timely reviews. With open access and rapid turnaround time from submission to publication the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.

III. Impact Factor History

Year2-Year IF3-Year IF4-Year IF
20228.6537.6756.994
20217.1326.4955.902
20204.1883.7403.368
20193.5383.1282.898
20182.9842.9682.720
20172.9682.6452.792
20163.1723.2603.231
20152.5122.5682.568
20142.929
20133.000

Note: impact factor data for reference only.

IV. SCImago Journal Rank (SJR)

SJR measures scientific influence, weighting citations by the prestige of the citing journal.

YearSJR Score
20232.384
20221.908
20211.301
20201.223
20190.941
20180.988
20170.842
20160.992
20150.971

V. H-Index

The H-Index measures both the productivity and citation impact of a journal's publications.

YearH-Index
202342.000
202235.000
202130.000

How to Get Published

https://ehoonline.biomedcentral.com/,https://www.editorialmanager.com/exho/default.aspx